Brown Miller Wealth Management, LLC Eli Lilly & CO Transaction History

Brown Miller Wealth Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Feb 11, 2025	BUY	$772.14 - $960.02 $343,602 - $427,208	445 New	445 $394,000
Q3 2024 Oct 10, 2024	BUY	$772.14 - $960.02 $91,884 - $114,242	119 Added 36.5%	445 $394,000
Q2 2024 Feb 11, 2025	BUY	$724.87 - $909.04 $236,307 - $296,347	326 New	326 $295,000
Q2 2024 Jul 12, 2024	BUY	$724.87 - $909.04 $9,423 - $11,817	13 Added 4.15%	326 $295,000
Q1 2024 Feb 11, 2025	BUY	$592.2 - $792.28 $185,358 - $247,983	313 New	313 $243,000
Q1 2024 Apr 17, 2024	BUY	$592.2 - $792.28 $185,358 - $247,983	313 New	313 $243,000

4,289

757M

10.2M

11.4M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $801B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Brown Miller Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Brown Miller Wealth Management, LLC with notifications on news.